tiprankstipranks
Analyst Profile
Followed by 81 other investors
.
David Turkaly

David Turkaly

JMP Securities
Wall Street Analyst
Ranked #1,845 out of 8,047 Analysts on TipRanks (#3,386 out of 21,521 overall experts)

Success Rate

51%
112 out of 219 Profitable Transactions

Average Return

5.60%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
If you copied David Turkaly's ratings since 2009 and opened each position for the duration of 1 Year:
51.14% of your transactions would have been profitable with an average return of 5.6%

Stock Rating Distribution

294Ratings
79.59% Buy
20.07% Hold
0.34% Sell
Distribution of David Turkaly's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Neuronetics
(STIM)
Rating Type:Buy
Dates:Mar 05, 2020 - Mar 05, 2021
Gain:416.90%
The most profitable rating made by David Turkaly

David Turkaly's Stock Coverage

Company Name
Date
Position
Action
Price Target
Success Rate
Avg Return
No. of Ratings
Orasure Technologies
Jun 25, 2009
Hold
Downgraded
0.00%
1
ARTC
ArthroCare
Mar 06, 2014
Hold
Downgraded
0.00%
1
~MR
Mindray Medical
Jun 08, 2015
Hold
Upgraded
0%
-9.80%
3
PennyMac Mortgage
Jun 03, 2016
Buy
Reiterated
$16.50
(6.59% Upside)
100%
+26.50%
1
New York Mortgage
Jun 03, 2016
Hold
Reiterated
0.00%
2
National Health Investors
Jun 03, 2016
Hold
Reiterated
0.00%
1
BCR
CR Bard
Sep 20, 2016
Buy
Reiterated
100%
+34.83%
5
MZOR
Mazor Robotics
May 12, 2017
Hold
Downgraded
100%
+85.37%
4
~CGNT
Cogentix Medical Inc
Oct 06, 2017
Buy
Initiated
100%
+23.60%
1
KTWO
K2M Group Holdings
Aug 30, 2018
Hold
Downgraded
100%
+64.53%
4
List of latest recommendations made by David Turkaly. Click to expand and see David Turkaly's performance on a particular stock
Disclaimer: TipRanks collects ratings and price targets of analysts by scanning publicly available reports on financial websites and by receiving reports directly from the analysts or from our users. The information displayed and the Analyst Profile statistics might not be accurate, complete, or up to date. The analyst ratings provided are entirely at the sole responsibility of the of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings or opinions expressed on the site.
Are We Missing a Rating?
Send us the equity research you are getting and become a Power User
Learn More